High-yield dividend stocks often catch investors' attention -- and for good reason. When established companies maintain ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

In contrast to AbbVie, Pfizer ( PFE 2.29%) stands out as more of a turnaround opportunity, offering investors the chance to ...

We recently published a list of the 8 Best Dividend Leaders to Buy According to Wall Street Analysts. In this article, we are ...

Pfizer's dividend isn't the only thing going for it. UPS is poised to turn the corner after a few bad years for its stock. If ...

Founded in 1849, and with a market cap of $146.7 billion, Pfizer (PFE) has evolved into a global pharmaceutical giant selling ...

Investment analysts at Leerink Partnrs lifted their FY2025 earnings estimates for Pfizer in a report issued on Wednesday, ...

Investment analysts at Leerink Partnrs lifted their Q3 2025 earnings per share (EPS) estimates for shares of Pfizer in a ...

We recently published a list of the 10 Best Stocks to Buy and Hold For 3 Years. In this article, we are going to take a look ...

Find out why high-yield blue-chip stocks are something you should seriously consider and the top seven blue-chip stocks with ...

Rob Isbitts talks to Brian Bollinger about their shared focus on dividend income using stocks like Verizon, Lowe's, ...